This has been a week of (almost) non-stop coverage of Abilify, which, in 2015, was the best-selling drug on earth.
In summary, Abilify (aripiprazole) is a “second-generation antipsychotic.” It’s both a dopamine partial agonist (activating postsynaptic dopamine receptors at low concentrations and blocking them at higher concentrations) as well as having …
Keep reading with a 7-day free trial
Subscribe to The Frontier Psychiatrists to keep reading this post and get 7 days of free access to the full post archives.